In response to low serum testosterone, male hypogonadism can be divided into two categories: hypogonadotrophic, with a reduced FSH and LH against low testosterone, as presented in patients with diabetes, obesity, relevant to metabolic syndrome [25]. This evidence concerns the gene PLOD1 and obesity due to melanocortin 4 receptor deficiency.